• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Vyome Holdings, Inc. - Common Stock (NQ:HIND)

    2.160 +0.030 (+1.41%)
    Streaming Delayed Price Updated: 4:00 PM EDT, Apr 6, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 12,038
    Open 2.150
    Bid (Size) 2.200 (4,700)
    Ask (Size) 2.260 (2,000)
    Prev. Close 2.130
    Today's Range 2.150 - 2.255
    52wk Range 1.750 - 6.560
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    Vyome to Present Compelling Phase 2 Clinical Data on VT-1953 for Treatment of MFW at AACR 2026
    From Vyome Holdings, Inc.
    Via Business Wire
    News headline image
    Vyome Reports Transformational 2025 Results: Company Well Positioned for Breakout Phase
    From Vyome Holdings, Inc.
    Via Business Wire

    Performance

    YTD
    -39.2%
    -39.2%
    1 Month
    -22.9%
    -22.9%
    3 Month
    -32.7%
    -32.7%
    6 Month
    -58.9%
    -58.9%
    1 Year
    -59.7%
    -59.7%

    More News

    Read More
    News headline image
    Livechain Completes Acquisition of Senior, Secured Debt of Humanyze, An MIT Incubated, AI Enabled HR Analytics Company
    From Vyome Holdings, Inc.
    Via Business Wire
    News headline image
    Vyome Announces the Publication of Positive Preclinical Results in Uveitis, Addressing a $3B Potential Market Opportunity
    From Vyome Holdings, Inc.
    Via Business Wire
    News headline image
    Vyome Files for VT-1953 Orphan Drug Status, Furthers Strategic Focus On VT-1953 Program Over the Next 6 Months
    From Vyome Holdings, Inc.
    Via Business Wire
    Keep an eye on the top gainers and losers in Wednesday's session. ↗
    Via Chartmill
    News headline image
    Vyome Successfully Capitalizes All VT-1953 Funding Requirements For Initial Phase 3 Results
    From Vyome Holdings, Inc.
    Via Business Wire
    Top movers analysis one hour before the close of the markets on 2026-01-28: top gainers and losers in today's session. ↗
    Via Chartmill
    Top movers analysis in the middle of the day on 2026-01-28: top gainers and losers in today's session. ↗
    Via Chartmill
    Gapping stocks in Wednesday's session ↗
    Via Chartmill
    Top movers in Wednesday's pre-market session ↗
    Via Chartmill
    Tuesday's after hours session: top gainers and losers ↗
    Via Chartmill
    News headline image
    Independent Analyst Values Vyome’s VT-1953 at USD 1 Billion Upon Successful Completion of Phase 3 Study
    From Vyome Holdings, Inc.
    Via Business Wire
    News headline image
    Vyome Subsidiary LiveChain (LICH) to Acquire Senior Secured Note in Humanyze, An MIT Incubated Company
    From Vyome Holdings, Inc.
    Via Business Wire
    News headline image
    Vyome Reports Positive Final Phase 2 Results for VT-1953; Plans to Advance Into Pivotal Study For FDA Approval
    From Vyome Holdings, Inc.
    Via Business Wire
    News headline image
    Vyome Appoints Renowned Medical Oncologist, Dr. Aditya Bardia, as Senior Medical Advisor to Guide the Development of MFW Program
    From Vyome Holdings, Inc.
    Via Business Wire
    News headline image
    Vyome Holdings Announces Transformational First Quarter Following Nasdaq Listing
    From Vyome Holdings, Inc.
    Via Business Wire
    News headline image
    Vyome Holdings Announces Results of Annual Shareholder Meeting
    From Vyome Holdings, Inc.
    Via Business Wire
    News headline image
    12 Health Care Stocks Moving In Friday's After-Market Session ↗
    Via Benzinga

    Frequently Asked Questions

    Is Vyome Holdings, Inc. - Common Stock publicly traded?
    Yes, Vyome Holdings, Inc. - Common Stock is publicly traded.
    What exchange does Vyome Holdings, Inc. - Common Stock trade on?
    Vyome Holdings, Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Vyome Holdings, Inc. - Common Stock?
    The ticker symbol for Vyome Holdings, Inc. - Common Stock is HIND on the Nasdaq Stock Market
    What is the current price of Vyome Holdings, Inc. - Common Stock?
    The current price of Vyome Holdings, Inc. - Common Stock is 2.160
    When was Vyome Holdings, Inc. - Common Stock last traded?
    The last trade of Vyome Holdings, Inc. - Common Stock was at 04/06/26 04:00 PM ET
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.